Durable Efficacy of Certolizumab Pegol Dosed at 400 mg Every Two Weeks Over 128 Weeks in Patients with Plaque Psoriasis Enrolled in Three Phase 3 Trials (CIMPASI-1, CIMPASI-2 and CIMPACT). J of Skin [Internet]. 2020 Sep. 2 [cited 2025 Jun. 8];4(5):s45. Available from: https://skin.dermsquared.com/skin/article/view/994